Searched for
FDA APPROVAL
Mark Cuban says AI hack agents are like cockroaches, but can be controlledCuban, famous for his role on business reality show "Shark Tank" and his involvement in the Dallas Mavericks NBA team, ventured into health...- ‘Looksmaxxing’ influencer Clavicular pleads not guilty to raping 17-year-old: Here’s more about the case and allegations against himBranden Eric Peters, popularly recognized as influencer Clavicular, stands accused of grave offenses, such as rape and drug-related charges...
- US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatmentHibsago, GSK's new hepatitis B treatment, recently secured approval from the US FDA, allowing patients to better manage their condition aft...
- Who is Tyler Shultz? The whistleblower who led to the toppling of Elizabeth Holmes’ $9 billion Theranos touted to become the ‘Apple of healthcare’Tyler Shultz became a whistleblower exposing Theranos, which was founded by Elizabeth Holmes in 2003. Holmes claimed Theranos could revolut...
- GLP-1 prices drop at Mochi Health, starting at $60 but what will patients actually pay?Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- British Indian pair, accused of cancer drug fraud, fight extradition to USA British Indian businessman and his ex-wife are fighting extradition to the US over allegations that they defrauded Medicare and other hea...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Cashless health insurance claims: What policyholders can do when hospitals and insurers clash over bills, approvals, and deductionsInflated bills, delayed approvals, arbitrary deductions. As hospitals and insurers trade charges, policyholders are left footing the bill. ...
- FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these f...
- Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...
- US FDA plans move to speed up vape, pouch approvals: ReportThe FDA is preparing to unveil new measures to accelerate approvals for vaping products and nicotine pouches. Changes will likely include r...
- New details in Presley Gerber’s death case hint at Ketamine; sources point to doctor reportedly prescribing the substancePresley Gerber, the son of renowned model Cindy Crawford, tragically passed away in a California rehabilitation facility on September 20, 2...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Can Fayuvi FDA approval lift RARE stock further?Ultragenyx Pharmaceutical shares surged 12.6% after FDA approval of Fayuvi, its gene therapy for Sanfilippo syndrome Type A, though the RAR...
- Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- AstraZeneca's breast cancer drug fails in late-stage trialAstraZeneca's breast cancer drug Etcamah did not meet its main goal in a late-stage trial. The drug showed only a numerical improvement whe...
Load More
